CORRECTION -- Gritstone Reports First Quarter 2022
-- Clinical programs continue progressing, with multiple Phase 2 data catalysts from neoantigen oncology vaccine programs and additional human data...
Stay updated with breaking news from Clinical Program Updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-- Clinical programs continue progressing, with multiple Phase 2 data catalysts from neoantigen oncology vaccine programs and additional human data...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
(2022-05-05 | NDAQ:GRTS) Gritstone Reports First Quarter 2022 Financial Results and Provides Business Update
Fusion Pharmaceuticals Announces Fourth Quarter 2021 Financial Results and Clinical Program Updates - Company is advancing first targeted... | March 17, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation. IMV Inc. Announces Fourth Quarter and Full Year 2020 Financial and Operational Results March 17, 2021 GMT DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--Mar 17, 2021-- IMV Inc. (the “Company” or “IMV”) (TSX: IMV; NASDAQ: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies, today announced its financial and operational results for the fourth quarter and year ended December 31, 2020. “Notwithstanding the challenges everyone faced in 2020, IMV’s commitment ...